All Updates

All Updates

icon
Filter
M&A
Genomenon acquires Clinical Knowledgebase from The Jackson Laboratory
Precision Medicine
May 8, 2024
This week:
Robinhood launches joint investment accounts
Retail Trading Infrastructure
Jul 25, 2024
Partnerships
eToro partners with London Stock Exchange to expand UK stock offerings
Retail Trading Infrastructure
Jul 25, 2024
Funding
StorMagic secures funding from Palatine Growth Credit Fund
Edge Computing
Jul 25, 2024
Funding
Archera raises USD 17 million in Series B funding for product development and recruitment
Cloud Optimization Tools
Jul 25, 2024
Funding
Alto Neuroscience receives grant of USD 11.7 million to support Phase IIb clinical trials of ALTO-100
Precision Medicine
Jul 25, 2024
Partnerships
Quest Diagnostics and BD partner to develop flow cytometry-based companion diagnostics for cancer and other diseases
Precision Medicine
Jul 25, 2024
Product updates
USPACE Technology Group Limited unveils commercial optical satellites and related aerospace products
Next-gen Satellites
Jul 25, 2024
Industry news
Sweden issues study on Gripen fighter jet’s satellite launch capability
Next-gen Satellites
Jul 25, 2024
Regulation/policy
Product updates
Terran Orbital receives certification for new manufacturing facility to begin production
Next-gen Satellites
Jul 25, 2024
Partnerships
Crisalion Mobility partners with Air Chateau for pre-order of eVTOL aircraft
Passenger eVTOL Aircraft
Jul 25, 2024
Precision Medicine

Precision Medicine

May 8, 2024

Genomenon acquires Clinical Knowledgebase from The Jackson Laboratory

M&A

  • Genomenon has acquired The Jackson Laboratory's Clinical Knowledgebase (CKB), a curated variant database used by oncology laboratories for interpreting complex cancer genomic profiles. The financial terms of the acquisition were undisclosed.

  • This acquisition accelerates Genomenon’s genome curation studies by providing insights into germline and somatic variants. Genomenon’s genomic research on germline clinical exome and AI-driven technology, combined with CKB’s data on somatic variants, will support researchers and clinicians with their interpretation of complex cancer genomic profiles.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.